| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/2013 | US8408200 For delivering an active agent formulation to the lung of a human |
| 04/02/2013 | CA2611727C Adhesive preparation |
| 04/02/2013 | CA2598558C Layered nanoparticles |
| 04/02/2013 | CA2582974C Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/02/2013 | CA2569067C Unagglomerated core/shell nanocomposite particles |
| 04/02/2013 | CA2565424C Macromolecule-containing sustained release intraocular implants and related methods |
| 04/02/2013 | CA2556248C Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 04/02/2013 | CA2525049C Insoluble globin injectable implant |
| 04/02/2013 | CA2510152C Temporary, pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing |
| 04/02/2013 | CA2491724C Ciclesonide-containing sterile aqueous suspension |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2464483C Microneedle transport device |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 03/29/2013 | CA2790749A1 Manufacturing method of patch preparation |
| 03/28/2013 | WO2013044219A1 Methods of treating cancers with therapeutic nanoparticles |
| 03/28/2013 | WO2013044186A1 Compositions and methods for molecular imaging of oxygen metabolism |
| 03/28/2013 | WO2013044098A1 Compositions and methods for treating conditions of compromised skin barrier function |
| 03/28/2013 | WO2013044045A1 Self-assembled nano-structure particle and method for preparing |
| 03/28/2013 | WO2013043985A1 Edible oils to enhance delivery of orally administered steroids |
| 03/28/2013 | WO2013043902A1 Targeted nanoparticles joined to reporter molecules through multiple mechanisms |
| 03/28/2013 | WO2013043866A1 Nicotine-containing pharmaceutical composition |
| 03/28/2013 | WO2013043839A1 Biosensor with error compensation |
| 03/28/2013 | WO2013043830A1 Nanoparticle formulations of poorly soluble compounds |
| 03/28/2013 | WO2013043828A1 Microspheres |
| 03/28/2013 | WO2013043719A1 Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance |
| 03/28/2013 | WO2013043637A1 Method and composition for treating pain |
| 03/28/2013 | WO2013043387A1 Ophthalmic gel compositions |
| 03/28/2013 | WO2013043142A1 Production method for pharmaceutical formulations comprising an isoflavone |
| 03/28/2013 | WO2013042989A1 Percutaneously absorbable preparation containing fentanyl and a homologue thereof |
| 03/28/2013 | WO2013042978A1 Method for preparing nano particles |
| 03/28/2013 | WO2013042834A1 Radionuclide marked and drug carrying polymer hydrogel and a production method therefor, and pharmaceutical composition for treating cancer comprising same as an active ingredient |
| 03/28/2013 | WO2013042149A1 Extracts obtained from vitis vinifera seeds and/or pomace and/or green grapes and/or stalks and uses thereof as antifungal agents |
| 03/28/2013 | WO2013042131A1 A process for preparation of synergistic herbal preparation of extracts picrorhiza kurroa and glycyrrhiza glabra having medicinal value |
| 03/28/2013 | WO2013042069A1 Emulsions and methods of making emulsions |
| 03/28/2013 | WO2013041851A1 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| 03/28/2013 | WO2013041696A1 Stimulating and invigorating nasal spray and nasal drop |
| 03/28/2013 | WO2013041646A1 Formulation and treatment for acne |
| 03/28/2013 | WO2013041572A1 Liposome production using isopropanol |
| 03/28/2013 | WO2013041542A1 Pharmaceutical formulations comprising spherolyophilisates of biological molecules |
| 03/28/2013 | WO2013041435A1 Compressed oral dosage form for asenapine maleate |
| 03/28/2013 | WO2013041206A1 Pharmaceutical combination drug |
| 03/28/2013 | WO2013040873A1 Sustained and controlled release of micro-granule formulation for treating intestinal disease and preparation method thereof |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | WO2013040784A1 Lyophilizing insulin liposome powder, oral insulin complex preparation, preparation method therefor, and use thereof |
| 03/28/2013 | WO2013019372A3 Thermally-conductive, metal-based bandages to aid in medical healing and methods of use |
| 03/28/2013 | WO2013013657A8 Compressed solid pharmaceutical composition comprising amorphous particulate valsartan as the active ingredient |
| 03/28/2013 | WO2013006692A3 Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) |
| 03/28/2013 | WO2012159077A9 Multiple dosing regimen oral drug delivery platform |
| 03/28/2013 | WO2012158622A3 Reversibly crosslinked micelle systems |
| 03/28/2013 | WO2012131001A3 Cushion for patient interface |
| 03/28/2013 | WO2012057212A9 Percutaneous absorption type formulation |
| 03/28/2013 | WO2011103920A3 Pharmaceutical or neutraceutical formulation |
| 03/28/2013 | WO2011039369A3 Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative |
| 03/28/2013 | US20130079767 Embolization |
| 03/28/2013 | US20130079749 Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead |
| 03/28/2013 | US20130079608 Implantable sensor method and system |
| 03/28/2013 | US20130079395 Novel process |
| 03/28/2013 | US20130079391 Lipase inhibiting composition |
| 03/28/2013 | US20130079344 Ophthalmologic irrigation solutions and method |
| 03/28/2013 | US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 03/28/2013 | US20130079311 Compositions and kits for compounding pharmaceuticals |
| 03/28/2013 | US20130078310 Multi-block copolymers for the preparation of stabilized micelles |
| 03/28/2013 | US20130078309 Oral particulate antitumor preparation |
| 03/28/2013 | US20130078308 Encapsulation device, medical capsules, and encapsulation method |
| 03/28/2013 | US20130078307 Nicotine-containing pharmaceutical composition |
| 03/28/2013 | US20130078306 Medicaments containing vardenafil hydrochloride trihydrate |
| 03/28/2013 | US20130078305 Pharmaceutical Compositions For The Coordinated Delivery Of NSAIDs |
| 03/28/2013 | US20130078304 Controlled release formulation for treating sleep disorders |
| 03/28/2013 | US20130078303 Soft-gelatin capsule formulation |
| 03/28/2013 | US20130078299 Transdermal Patches Having Ionized Beam Crosslinked Polymers and Improved Release Characteristics |
| 03/28/2013 | US20130078292 Composition for preventing or treating dentin-associated symptoms or diseases, and method using the same |
| 03/28/2013 | US20130078288 Method of Treating Cancer |
| 03/28/2013 | US20130078287 Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist |
| 03/28/2013 | US20130078286 Drug delivery system |
| 03/28/2013 | US20130078284 Pharmaceutical formulations |
| 03/28/2013 | US20130078283 Novel amphiphiles |
| 03/28/2013 | US20130078282 Formulations decreasing particle exhalation |
| 03/28/2013 | US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 03/28/2013 | US20130075703 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/28/2013 | DE102011114986A1 Sprühsystem Spray system |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2851492A1 Ophthalmic gel compositions |
| 03/28/2013 | CA2849822A1 Novel influenza hemagglutinin protein-based vaccines |
| 03/28/2013 | CA2849378A1 Nano delivery systems |
| 03/28/2013 | CA2849279A1 Interomone compositions and their use to modify behavior in different vertebrate species |
| 03/28/2013 | CA2849184A1 Liposome production using isopropanol |
| 03/28/2013 | CA2849078A1 Method and composition for treating pain |
| 03/28/2013 | CA2849037A1 Microbubble complexes and methods of use |
| 03/28/2013 | CA2849025A1 Self-assembled nano-structured particle and method for preparing |
| 03/28/2013 | CA2848943A1 Compositions and methods for treating conditions of compromised skin barrier function |
| 03/28/2013 | CA2848488A1 Method for preparing nano particles |
| 03/28/2013 | CA2847033A1 Dispersion anaesthetic device |
| 03/28/2013 | CA2834327A1 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| 03/27/2013 | EP2572780A1 Vesicles with encapsulated substance and production method therefor |
| 03/27/2013 | EP2572731A1 Formulations based on solid dispersions |
| 03/27/2013 | EP2572723A2 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 03/27/2013 | EP2572720A1 Formulation and treatment for acne |
| 03/27/2013 | EP2572717A1 Pharmaceutical composition containing solifenacin |
| 03/27/2013 | EP2572708A1 Method of preparation of biocompatible polymer nanocapsules for drug encapsulation |
| 03/27/2013 | EP2572707A2 Microparticles with adsorbed polypeptide-containing molecules |